Jentzsch M, Grimm J, Bill M, Kupper J, et al. Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation. Bone Marrow Transplant 2021 Jul 15. pii: 10.1038/s41409-021-01407.
PMID: 34267355